S. Fürst

748 total citations
17 papers, 394 citations indexed

About

S. Fürst is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Fürst has authored 17 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in S. Fürst's work include Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). S. Fürst is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Lymphoma Diagnosis and Treatment (4 papers) and Acute Myeloid Leukemia Research (3 papers). S. Fürst collaborates with scholars based in France, United States and Italy. S. Fürst's co-authors include Didier Blaise, Jean El Cheikh, Catherine Faucher, Mohamad Mohty, Norbert Vey, Christian Chabannon, Luca Castagna, Réda Bouabdallah, Diane Coso and Roberto Crocchiolo and has published in prestigious journals such as Annals of Oncology, Leukemia and Clinical Microbiology and Infection.

In The Last Decade

S. Fürst

17 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Fürst France 10 286 122 105 91 59 17 394
Arancha Bermúdez Spain 9 212 0.7× 162 1.3× 64 0.6× 52 0.6× 95 1.6× 25 371
Irene García‐Cadenas Spain 11 270 0.9× 198 1.6× 84 0.8× 94 1.0× 33 0.6× 45 407
Albert Esquirol Spain 13 297 1.0× 199 1.6× 75 0.7× 73 0.8× 41 0.7× 45 433
Radwan Massoud Lebanon 12 245 0.9× 158 1.3× 88 0.8× 37 0.4× 56 0.9× 51 397
Dolores Grosso United States 9 224 0.8× 114 0.9× 137 1.3× 132 1.5× 47 0.8× 49 392
Yuju Ohno Japan 10 254 0.9× 121 1.0× 78 0.7× 106 1.2× 42 0.7× 34 381
Joanne Filicko-O’Hara United States 9 189 0.7× 83 0.7× 107 1.0× 80 0.9× 45 0.8× 48 302
Nicole Raus France 10 183 0.6× 62 0.5× 63 0.6× 49 0.5× 42 0.7× 23 259
Amandine Le Bourgeois France 12 220 0.8× 166 1.4× 161 1.5× 55 0.6× 37 0.6× 62 437
Sameh Ayari France 12 232 0.8× 144 1.2× 71 0.7× 72 0.8× 18 0.3× 23 345

Countries citing papers authored by S. Fürst

Since Specialization
Citations

This map shows the geographic impact of S. Fürst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fürst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fürst more than expected).

Fields of papers citing papers by S. Fürst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Fürst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fürst. The network helps show where S. Fürst may publish in the future.

Co-authorship network of co-authors of S. Fürst

This figure shows the co-authorship network connecting the top 25 collaborators of S. Fürst. A scholar is included among the top collaborators of S. Fürst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Fürst. S. Fürst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chabannon, Christian, Réda Bouabdallah, S. Fürst, et al.. (2019). CAR-T cells : lymphocytes exprimant un récepteur chimérique à l’antigène. La Revue de Médecine Interne. 40(8). 545–552. 2 indexed citations
2.
O’Donnell, Paul V., Mary Eapen, Mary M. Horowitz, et al.. (2016). Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. Bone Marrow Transplantation. 51(12). 1599–1601. 31 indexed citations
3.
Bouabdallah, Krimo, S. Fürst, Julien Asselineau, et al.. (2014). 90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas. Annals of Oncology. 26(1). 193–198. 4 indexed citations
4.
Castagna, Luca, Stéfania Bramanti, S. Fürst, et al.. (2014). Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas. Bone Marrow Transplantation. 49(12). 1475–1480. 26 indexed citations
6.
Venton, Geoffroy, Roberto Crocchiolo, S. Fürst, et al.. (2013). Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients. Clinical Microbiology and Infection. 20(2). 160–166. 43 indexed citations
7.
Malard, Florent, S. Fürst, Marion Loirat, et al.. (2013). Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning. Leukemia. 27(11). 2113–2117. 11 indexed citations
8.
Devillier, Raynier, Roberto Crocchiolo, Luca Castagna, et al.. (2012). The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT. Bone Marrow Transplantation. 47(5). 639–645. 56 indexed citations
9.
Crocchiolo, Roberto, Luca Castagna, S. Fürst, et al.. (2012). Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 48(2). 249–252. 9 indexed citations
10.
Castagna, Luca, S. Fürst, Diane Coso, et al.. (2012). Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT. Bone Marrow Transplantation. 48(6). 794–798. 6 indexed citations
11.
Devillier, Raynier, Luca Castagna, Jean El Cheikh, et al.. (2012). TLI in refractory chronic GVHD. Bone Marrow Transplantation. 48(6). 854–858. 6 indexed citations
12.
Crocchiolo, Roberto, Luca Castagna, Jean El Cheikh, et al.. (2011). Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients. Experimental Hematology. 39(9). 892–896. 15 indexed citations
13.
Castagna, Luca, S. Fürst, Jean El Cheikh, et al.. (2010). Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT. Bone Marrow Transplantation. 46(7). 1000–1005. 34 indexed citations
15.
Lavallade, Hugues de, Jean El Cheikh, Catherine Faucher, et al.. (2008). Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma. Bone Marrow Transplantation. 41(11). 953–960. 53 indexed citations
16.
Cheikh, Jean El, C. Faucher, S. Fürst, et al.. (2007). High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation. 39(5). 301–306. 47 indexed citations
17.
Mohty, Mohamad, Béatrice Gaugler, Catherine Faucher, et al.. (2006). The cytokine storm and acute graft-versus-host disease (aGVHD) after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT). Biology of Blood and Marrow Transplantation. 12(2). 13–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026